Sanofi top pharmaceuticals revenue change 2018

Change in revenue of Sanofi's top pharmaceuticals in 2018 compared to previous year*

by Matej Mikulic, last edited Mar 11, 2019
Sanofi top pharmaceuticals revenue change 2018 This statistic shows the change in revenue of Sanofi's top pharmaceuticals in 2018 compared to the previous year. Dupixent, a rare blood disorder drug, showed the highest growth rate among all of Sanofi's best-selling pharmaceutical drugs.
Show more

Change in revenue of Sanofi's top pharmaceuticals in 2018 compared to previous year*

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "Sanofi"
  • Global positioning
The most important statistics
  • Overview
  • Revenue distribution
  • Company shares
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.